-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2021 to Q2 2024.
- BioXcel Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $77K, a 4.94% decline year-over-year.
- BioXcel Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $312K, a 4.59% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Depreciation for 2023 was $318K, a 2.75% decline from 2022.
- BioXcel Therapeutics, Inc. annual Depreciation for 2022 was $327K, a 10.1% increase from 2021.
- BioXcel Therapeutics, Inc. annual Depreciation for 2021 was $297K, a 58% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)